TransMedics Group Reports Q1 2026 Results

What Happened
TransMedics Group, Inc. announced its financial results for the quarter ended March 31, 2026 by issuing a press release on May 5, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8-K (Item 2.02), reporting its quarterly results and condition.

Key Details

• Press release issued and furnished on May 5, 2026, covering the quarter ended March 31, 2026.
• Disclosure made under Item 2.02 (Results of Operations and Financial Condition); the press release is attached as Exhibit 99.1.
• The Form 8-K states the furnished information is not “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except where expressly stated.
• The report was signed on behalf of the company by Gerardo Hernandez, Chief Financial Officer and Treasurer.

Why It Matters
Earnings announcements provide the primary, company-approved source for revenue, profit/loss, and other performance metrics that investors use to assess near-term outlook. Because the press release is furnished via Form 8-K, investors should read Exhibit 99.1 for the specific financial figures and commentary from management to evaluate TransMedics’ quarterly performance and any potential impacts on the stock.